Description: CJC-1295 (with DAC) is a long-acting GHRH analog examined for its impact on the growth hormone axis in research applications. Researchers buy CJC-1295 to study GH/IGF-I dynamics under controlled conditions. Investigations have explored its benefits and ability to extend growth hormone release, influence metabolic processes, and support tissue growth models. The inclusion of DAC (Drug Affinity Complex) extends its half-life, allowing for prolonged activity in experimental settings. Supplied as a 5mg lyophilized vial for professional laboratory use only.
Product Details:
• Compound: CJC-1295 with DAC
• Form: Lyophilized powder
• Amount: 5mg per vial
• Appearance: White/off-white powder
• Purity: >99% (HPLC Verified)
• Molecular Formula: C165H271N47O46
• Storage: Store at -20°C in a dry, dark place
Intended Use:
This compound is intended for laboratory research use only.
It is not intended for human consumption, medical, or diagnostic purposes.
Related Research Studies:
- CJC‑1295, a long‑acting GHRH analog, increases GH and IGF‑I in humans (JCEM). Phase I studies reported sustained increases in GH and IGF‑I after single and multiple doses of CJC‑1295.
- Pharmacokinetics and tolerability of CJC‑1295 (Clin Pharmacol). Describes PK profile and safety/tolerability of CJC‑1295 with drug‑affinity complex (DAC) in early human studies.
Related Products:
